Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2025, on Tuesday, October 28, 2025, following the close of trading on ...

More IPO aspirants are reaching out to IR agencies, prompting these firms to expand their teams and seek professionals with ...

Done well, fractional IR becomes not an outsourced stopgap but an embedded lever in a firm’s capital formation system.

ELKO, NV / ACCESS Newswire / September 17, 2025 / Patriot Critical Minerals ("Patriot" or the "Company"), a U.S.-based critical minerals developer advancing the 100%-owned MEGA tungsten project in ...

WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”) , a biopharmaceutical company specializing in the development and commercialization ...

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Financial Services Virtual ...

ACME Capital, an early-stage venture capital firm, announced the appointment of Katera Mujadidi as Partner and Head of Investor Relations. In this role, Katera will help shape the firm's strategy and ...

Climb Bio appointed Susan Altschuller chief financial officer as the clinical-stage biotechnology company pushes ahead with the development of two flagship therapeutics for patients with ...

Before this appointment, Rosatelli resigned from his position as a Zenvia Board Member. His professional background is ...

ResMed has appointed Salli Schwartz as the new Chief Investor Relations Officer, effective April 21, 2025. Schwartz brings over two decades of experience from roles in finance at health tech and ...

Access the playbook now to see how you can elevate your IR strategy for long-term value. Not only can that intelligence go to inform their company’s future disclosures and pre-empt the questions that ...